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Organismal stress initiates a tightly orchestrated set of responses involving complex physiological and neurocognitive systems. Here, we
present evidence for glucagon-like peptide 1 (GLP-1)-mediated paraventricular hypothalamic circuit coordinating the global stress
response. The GLP-1 receptor (Glp1r) in mice was knocked down in neurons expressing single-minded 1, a transcription factor abun-
dantly expressed in the paraventricular nucleus (PVN) of the hypothalamus.Mice with single-minded 1-mediatedGlp1r knockdown had
reduced hypothalamic-pituitary-adrenal axis responses to both acute and chronic stress and were protected against weight loss associ-
ated with chronic stress. In addition, regional Glp1r knockdown attenuated stress-induced cardiovascular responses accompanied by
decreased sympathetic drive to the heart. Finally, Glp1r knockdown reduced anxiety-like behavior, implicating PVN GLP-1 signaling in
behavioral stress reactivity. Collectively, these findings support a circuit whereby brainstemGLP-1 activates PVN signaling tomount an
appropriate whole-organism response to stress. These results raise the possibility that dysfunction of this system may contribute to
stress-related pathologies, and thereby provide a novel target for intervention.
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Introduction
Stress-related information is received and integrated in the brain,
which activates adaptive (behavioral and physiological) re-
sponses to restore ormaintain homeostasis. Dysfunction of stress
adaptation can contribute to a variety of pathological conditions
(Chrousos and Gold, 1992; de Kloet et al., 2005; Grippo, 2009).
Despite a wealth of data linking stress and disease, the neural
pathways underpinning these connections are only gradually be-
coming understood. Physiological responses to stressors cause
rapid activation of the sympathetic nervous system and promote
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Significance Statement
Dysfunctional stress responses are linked to a number of somatic andpsychiatric diseases, emphasizing the importance of precise
neuronal control of effector pathways. Pharmacological evidence suggests a role for glucagon-like peptide-1 (GLP-1) inmodulat-
ing stress responses. Using a targeted knockdown of the GLP-1 receptor in the single-minded 1 neurons, we show dependence of
paraventricular nucleus GLP-1 signaling in the coordination of neuroendocrine, autonomic, and behavioral responses to acute
and chronic stress. To our knowledge, this is the first direct demonstration of an obligate brainstem-to-hypothalamus circuit
orchestrating general stress excitation across multiple effector systems. These findings provide novel information regarding
signaling pathways coordinating central control of whole-body stress reactivity.
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glucocorticoid hormone release by the hypothalamic-pituitary-
adrenocortical (HPA) axis (Ulrich-Lai and Herman, 2009).
Stress-induced activation of the sympathetic nervous system rap-
idly increases heart rate (HR) and blood pressure (among other
effects) (Carter and Goldstein, 2015). The HPA axis response is
initiated by corticotropin-releasing hormone neurons of the hy-
pothalamic paraventricular nucleus (PVN), which stimulate
ACTH release and consequent secretion of glucocorticoids by the
adrenal glands (Herman et al., 2016). These systems, both pro-
voked by stress, act in a mutual and coordinated fashion to mo-
bilize central and peripheral energetic resources over both
immediate and extended periods of time, allowing reaction to or
anticipation of threat and recovery of homeostasis (Ulrich-Lai
and Herman, 2009).
Recently, glucagon-like peptide 1 (GLP-1) has been hypothe-
sized to be an important component of brain mechanisms regu-
lating stress adaptation (Ghosal et al., 2013). Although originally
identified as a gastrointestinal hormone (Varndell et al., 1985),
GLP-1 is also produced in the brain by neurons largely confined
to the caudal division of the nucleus of the solitary tract (NTS)
and the ventral medulla (Merchenthaler et al., 1999). Impor-
tantly, the GLP-1 receptor (Glp1r) is abundantly expressed in the
PVN (Merchenthaler et al., 1999), and GLP-1-immunoreactive
fibers derived from the NTS innervate both neuroendocrine and
preautonomic PVN neurons (Vrang et al., 2007; Tauchi et al.,
2008), suggesting possible involvement in stress reactivity. In-
deed, pharmacological studies demonstrate that GLP-1 receptor
antagonism reduces HPA axis responses to both reactive (physi-
cal) and anticipatory (emotional) stressors (Kinzig et al., 2003),
and central administration of GLP-1 receptor agonists activates
hypothalamic and brainstem neurons innervating sympathetic
preganglionic neurons (Yamamoto et al., 2002, 2003). The clear
interaction between HPA- and sympatho-excitatory NTS GLP-1
projections and putative PVN stress effector neurons led us to
hypothesize that endogenous GLP-1 neurons form a dedicated
neurocircuit coordinating differentmodalities of stress responses
at the level of the PVN. To address this hypothesis, we developed
a mouse model with targeted knockdown (KD) of Glp1r in the
single-minded 1 (Sim1)-expressing neurons. Our findings dem-
onstrate that Sim1-mediated KD of the Glp1r in the PVN of the
hypothalamus is required for neuroendocrine, sympathetic, and
behavioral responses to stressors of both physical and emotional
origin, consistent with a critical role for NTS GLP-1 neurons in
driving the whole-organism response to stress.
Materials andMethods
Animals. Sim-1-Cre; Glp1r f/f mice were generated by crossing Glp1r f/f
mice (Smith et al., 2014) with Sim1-Cre mice (Balthasar et al., 2005), a
kind gift fromDr. J. Elmquist (University of Texas SouthwesternMedical
Center, Dallas). To generate litters that contained both genotypes (Sim1-
Cre, Glp1r f/f and Glp1r f/f), the dams were Glp1r f/f and the sires were
Glp1r f/f mice heterozygous for the Sim1-Cre transgene. The experiments
reported here were performed on 10- to 12-week-old male Sim-1-Cre;
Glp1r f/f (homozygous for Glp1r flox [Glp1r f/f] and expressing Sim1-Cre
and littermateGlp1r f/f [Control] mice). To test for possible effects of the
Sim1-Cre transgene on stress outcomes, Sim1-Cre and wild-type litter-
mates were generated by crossing Sim1-Cre male and wild-type (wt)
C57BL/6 femalemice (Harlan Laboratories). Experiments reported were
performedon 10- to 12-week-oldmale Sim-1-Cre and littermatewtmice.
Mice were housed in a temperature-controlled facility on a 12 h light/
dark schedule (lights on at 0600 h) unless otherwise noted.Mice were fed
either standard rodent chow (Harlan Laboratories; 3.1 kcal/g;5% fat)
or a high-fat diet (Research Diets; 4.54 kcal/g;40% fat) as appropriate.
Food and water were provided ad libitum unless otherwise noted. All
experiments were approved by the University of Cincinnati Institutional
Animal Care and Use Committee and were performed in accordance
with the NIH Guide for the care and use of laboratory animals.
RNA isolation and quantitative PCR expression analysis. RNA extrac-
tion and real-timePCRwere performed as previously described (Smith et
al., 2014). Briefly, mice (n 4 or 5 per group) were rapidly decapitated
and the brains removed and flash-frozen in dry ice-chilled isopentane.
The brain regions were dissected from flash-frozen brains in the cryostat
(Microm HM550MP) at 16°C on the day of RNA extraction using
microdissectionmethod. Brainswere placed on cooledmetal block in the
cryostat, areas of interest identified based on morphological landmarks
and coronal sections cut at a thickness of 500m. Sectionsweremounted
on a chilled slide and bilateral tissue punches obtained using a microdis-
section needle with a diameter of 0.5 mm. Targeted regions included
areas known to (1) express Glp1r and/or Sim1 and (2) have putative
involvement in stress processing. Tissues collected included the entire
rostral to caudal extent of PVN (anterior margin: bregma 0.58 mm,
posterior margin: bregma 1.08 mm); the arcuate nucleus (anterior
margin: bregma1.46 mm, posterior margin: bregma2.00 mm); the
central nucleus of the amygdala (anterior margin: bregma 0.94 mm,
posterior margin: bregma 1.50 mm); the medial amygdala (anterior
margin: bregma 1.6 mm, posterior margin: bregma 2.06 mm); the
supraoptic nucleus (SON) (anterior margin: bregma0.58 mm, poste-
rior margin: bregma0.94 mm); the bed nucleus of the stria terminalis
(anteriormargin: bregma 0.62mm, posteriormargin: bregma 0.02mm);
the lateral septum (anterior margin: bregma 0.62 mm, posterior margin:
bregma 0.02 mm); and the NTS (anterior margin: (bregma 7.08 mm,
posterior margin: bregma 8.24 mm). All coordinates were obtained
according to Paxinos and Franklin (2004) mouse brain atlas, with ana-
tomical landmarks (e.g., white matter tracts) used as landmarks. Tissue
punches were homogenized in lysis buffer provided by the RNAqueous-
Micro kit (Ambion, Invitrogen). RNA from adrenal gland, kidney, pitu-
itary gland, and heart was isolated using RNeasy columns (QIAGEN),
according to the manufacturer’s instructions. DNase treatment
(QIAGEN) was performed tominimize genomic DNA contamination of
the RNA extract. Subsequently, cDNAs were synthesized with Super-
Script III First-Strand Synthesis kit (Invitrogen) as described previously
(Smith et al., 2014). Expression levels were evaluated by quantitative
real-time PCR (qPCR) using a TaqMan 7900 Real time System with
TaqMan Gene Expression Fast Master Mix and gene-specific TaqMan
probes (Invitrogen). PCR primers were as follows: -actin, 4352341 E
and Glp1r (Mm00445292.m1, primers spanning the deleted exons 6 and
7), as a target gene. Glp1r expression pattern was normalized to consti-
tutively expressed-actin, and relative expression patternwas quantified
using the method (Livak and Schmittgen, 2001).
RNAscope multiplex fluorescent assay. Double fluorescent RNAscope
assay was performed on fresh-frozen brain tissues containing PVN col-
lected from Sim1-Cre,Glp1r f/f, and littermateGlp1r f/f mice, according to
the manufacturer’s instructions with minor modification. The brains
were collected and placed in a cryostat at 20°C for 2 h to allow for
temperature equilibration, and then sliced at a thickness of 12 m. Sec-
tions were thaw-mounted onto Superfrost Plus slides. The slides were
allowed to stand at20°C for 10min and then stored at80°C until use.
The fixation, protease digestion, probe hybridization, preamplification,
amplification, and fluorescent labeling steps were performed according
to the manufacturer’s instructions (Advanced Cell Diagnostics). For de-
tection ofmRNA, amouseGlp1r probe conjugated to Cy3 andCrh probe
conjugated to AlexaFlour-488 sequences were custom-made by Ad-
vanced Cell Diagnostics using 6 ZZ pairs targeting the exons 6 and 7 of
theGlp1r gene (NM_021332.2, 584–855) and 20 ZZ pairs targeting exon
2 of theCrh gene(NM_205769.2, 157–1262). Images were captured using
AxioImager with Apotome, AxioCam Camera, Axio Vision Rel. 4.6 soft-
ware (Carl Zeiss) at 63. Images were pseudo-colored (Crh, green; and
Glp1r, red). mRNA signal, as represented by each punctate dot in the
entire field of the image, was quantified using ImageJ (National Institutes
of Health) software tool. Images were processed using ImageJ option
“Despeckle” to remove single pixel background staining and then con-
verted into binary images and skeletonized. The image was them ana-
lyzed using ImageJ “measure” tool.
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Basal HPA axis regulation. To assess basal circadian corticosterone
levels, tail blood (15–20 l) samples from Sim1-Cre; Glp1r f/f and litter-
mate Glp1r f/f (n 9 per group) mice were taken on two occasions, once
during the A.M. at 0800 h (circadian nadir) and once during the P.M.
(circadian peak) at 1500 h. To test involvement of Sim1-Cre expression in
basal HPA regulation, additional groups of Sim1-Cre and littermate wt
mice (n 9 per group) were tested as above.
HPA axis regulation to acute stress. To assess HPA axis (ACTH and
corticosterone) responses to an acute novel restraint challenge, mice
[Sim1-Cre; Glp1r f/f and littermates Glp1r f/f (n  6 per group)] were
placed inwell-ventilated 50ml conical tubes for 20 (for ACTH) or 30 (for
corticosterone) min. For the analysis of ACTH concentrations, mice un-
derwent rapid decapitation and trunk blood (500 l) was collected 20
min after restraint stress exposure. The restraint stress exposure for this
particular experiment was limited to 20 min to allow us to capture peak
stress-induced ACTH concentrations. The blood was stored and pro-
cessed as described in the radioimmunoassay section. For analyzing cor-
ticosterone responses, tail blood samples were taken at 0 (prestress), 30,
60, and 120 min from Sim1-Cre; Glp1r f/f and littermates Glp1r f/f (n 9
per group). The 60 and 120 min time points were free-bleed poststress
measures, as the mice had been removed from the restraint tubes and
were placed back into the home cages. To preclude effects of Sim1-Cre
transgene expression on stress reactivity, additional groups of Sim1-Cre
and littermate wt mice (n  7 per group) were also tested, using an
identical stress and sampling protocol. For assessment of corticosterone
responses to a systemic stress, mice Sim1-Cre; Glp1r f/f and littermate
Glp1r f/f (n 9 per group) were placed in a clear Plexiglas chamber with
clean bedding and exposed to 8% oxygen and 92% nitrogen for 30 min.
Tail blood samples were taken at 30, 60, and 120 min after the initiation
of hypoxia.
HPA axis regulation to chronic stress. Regulation of the HPA axis fol-
lowing chronic stress was determined in a separate set of Sim1-Cre;
Glp1r f/ f and littermate Glp1r f/f mice. Mice underwent a 2 week chronic
variable stress (CVS) regimen or remained in their home cages for the
duration of the experiment (no CVS controls). Thus, this experiment
included four groups ofmalemice: noCVSGlp1r f/f (n 7), CVSGlp1r f/f
(n 7), no CVS Sim1-Cre; Glp1r f/f (n 7), and CVS Sim1-Cre; Glp1r f/f
(n  8). Mice in the CVS group were exposed to twice-daily randomly
presented stressors with occasional overnight stressors (CVS regimen is
described in Table 1). Body weight was assessed on a weekly basis. On the
morning after completion of the CVS (day 15), all mice were given a
novel restraint stress challenge for 30 min. Mice were then overdosed
with sodium pentobarbital and perfused. Adrenal and thymus glands
were collected, cleaned, and weighed.
ACTH and corticosterone radioimmunoassay. Tail blood was collected
into chilled EDTA-coated tubes. Plasma was separated by centrifugation
at 4°C 6000 rpm for 15min and stored at20°C. Tail blood sampleswere
collected within 2 min from the initial handling of the mouse cage.
Plasma corticosterone concentrations were determined using 125I radio-
immunoassay kits (MP Biomedicals). Plasma ACTH concentrations
were determined by a radioimmunoassay using a specific antiserum gen-
erously donated by Dr. William Engeland (University of Minnesota,
Minneapolis) at a dilution of 1:120,000,with 125I ACTH(GEHealthcare)
as a labeled tracer. All samples were run in duplicate, and all samples were
run in the same assay. The intra-assay coefficient of variation was10%
for both assays.
Tail blood glucose. Tail blood glucose level from freely moving mice
was measured at, 0, 30, 60, and 120 min following restraint and hypoxia
using a Roche Accu-Check glucometer as described previously (Smith et
al., 2014).
PVN Fos immunoreactivity. PFA-perfused brains from acutely stressed
Sim1-Cre; Glp1r f/f and littermates Glp1r f/f mice (n 6 per group) were
sectioned at 25 m and immunolabeled for Fos (1:2500; Santa Cruz
Biotechnology, sc-52) using standard immunostaining procedures as de-
scribed previously (Ghosal et al., 2014). The number of Fos-positive cells
was counted bilaterally for each section and expressed as cells per unit
area (mm2). An observer blinded to the treatment conditions counted
cells.
Radiotransmitter implantation and telemetric recording for cardiovascu-
lar studies.Mice [Sim1-Cre; Glp1r f/f and littermatesGlp1r f/f (n 6–8 per
group)] were anesthetized with 2% isoflurane, vaporized with 100% ox-
ygen. Telemetry devices (PA-C10, Data Sciences International) were im-
planted subcutaneously and anchored with suture to the abdominal
muscle wall without occluding the animal’s mobility. The catheter tip
was inserted into the animals’ left carotid artery in a way that it enters the
aorta. Mice were allowed to recover for 2 weeks before the onset of the
study followed by continuous recording of resting and stress-induced
cardiovascular parameters (BP, HR, and locomotor activity). Following
recovery from the telemetry surgery (2 weeks), Sim1-Cre; Glp1r f/f and
littermate Glp1r f/f mice were left undisturbed in their home cage for 7 d.
Resting mean arterial pressure (MAP), HR, and activity were recorded
continuously, and were determined using A.R.T. Platinum software
(DSI). These data were averaged as the mean values per hour over the
entire day.
Cardiovascular responses to a novel acute restraint. For assessment of
cardiovascular responses to a novel acute restraint, each mouse was
placed into a restrainer (a well-ventilated 50 ml conical plastic tube) for
30min. At the end of the 30min, mice were released from the restrainers
into their home cages. The exact time at which mice were placed into the
restrainer was considered the 0min time point. Cardiovascular data were
collected and analyzed before restraint (60 min during the morning be-
fore the test), throughout that restraint period (30min), and throughout
the recovery period (90 min after the restraint). HR, MAP, and locomo-
tor activity were measured in 10 min bins. To determine the relative
contribution of sympathetic versus parasympathetic nervous system in
the stress-induced cardiovascular responses, pharmacological tests using
propranolol (-adrenergic receptor antagonist, 4 mg/kg, Sigma), atro-
pine methyl nitrate (cholinergic receptor antagonist, 0.5 mg/kg, Sigma),
and hexamethonium (a ganglionic blocker, 0.2 mg/kg, Sigma) were per-
formed. The antagonists were given in the following order: (1) propran-
olol, (2) atropine methyl nitrate, and (3) hexamethonium. One week
intervened between the three tests.
Elevated plus maze (EPM). Mice [Sim1-Cre; Glp1r f/f and littermate
Glp1r f/f were placed on a Plexiglas EPM apparatus for 5 min to assess
anxiety-related behaviors. The EPM experiments were performed using
two separate cohorts of mice (n 7–9 per group/study). We first tested
the baseline anxiety-like behaviors in nonstressed Sim1-Cre; Glp1r f/f and
littermate Glp1r f/f mice. In the second EPM, we tested the anxiety-like
behaviors in both genotypes following exposure to prior stressors (10
min swim and 1 h of rotation at 100 rpm). The EPM experiments were
performed between 9:00 A.M. and 12:00 P.M. In this test, mice were
placed in the center of the plus maze facing an open arm, and behavior
Table 1. Daily schedule for the CVS procedure (2 stressors/d; 2 weeks)a
Week 1 Week 2
Day A.M. P.M. Day A.M. P.M.
1 FST (10 min) Cage rotation (1 h) 8 EPM (10 min) Cold (4°C, 1 h)
2 EPM (5 min) Hypoxia (30 min) 9 OF (5 min) Hypoxia (30 min)
3 OF (5 min) Wet bedding (1 h) 10 Cage rotation (1 h) Hypoxia (30 min)
4 Cage rotation (1 h) Cold (4°C, 1 h) 11 Wet bedding (1 h) Cold (4°C, 1 h)
5 EPM (5 min) Hypoxia (30 min) 12 EPM (5 min) Isolation housing (O/N)
6 Wet bedding (1 h) Cold (4°C, 1 h) 13 Tilted cage (O/N) Cage rotation (1 h)
7 OF (5 min) Tilted cage (O/N) 14 FST (10 min) Hypoxia (30 min)
aThe stressor types and duration are shown. OF, Open field; O/N, overnight.
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was recorded for the entire time period using an overhead mounted
camera. Topscan software (Clever System) was used to measure time
spent in the open and closed arm in the EPM, total distance traveled in
the maze (locomotor activity), and number of entries into the open arm.
The apparatus was thoroughly cleaned with 20% ethanol before each
mouse was tested. Anxiety-related behavior is associated with less explo-
ration of the open arm relative to overall exploration of all arms.
Forced swim test (FST). Mice [Sim1-Cre; Glp1r f/f and littermate
Glp1r f/f (n  7 or 8 per group)] were exposed to a cylinder (2 L glass
beaker) filledwithwater (23°C–25°C) for 10min. The FSTwas selected to
assess depression-like behavior under naive conditions as well as follow-
ing 14 d of CVS. The entire behavioral session was videotaped.Measured
parameters included immobility (not making any active movement or
floating in the water without struggling) and active behaviors (swim-
ming). Time spent immobile was scored using Hindsight, Version 1.5
(Scott Weiss) as described previously (Ghosal et al., 2014). Behaviors
were scored by an investigator blind to the experimental conditions.
Food intake studies. Anorectic effect of exendin-4 (Ex-4, GLP-1 recep-
tor agonist) in Sim1-Cre; Glp1r f/f and littermates Glp1r f/f was tested as
previously described (Smith et al., 2014). Mice [Sim1-Cre; Glp1r f/f and
littermatesGlp1r f/f (n 9 per group)] were fasted 4 h before the onset of
dark phase. Ex-4 (Amylin Pharmaceuticals; 100 g/kg) or saline was
injected into the peritoneum(i.p.) at the beginning of the dark phase, and
food intake was measured after 1, 2, 4, 6, and 24 h.
Body composition analysis. Body composition (leanmass and fat mass)
was analyzed by MRI using a whole-body composition analyzer (Echo-
Medical Systems) as described previously (Sisley et al., 2014).
Statistical analysis. Data are expressed as mean  SEM. Sample sizes
were based on previous hormonal and behavioral experiments in our
laboratory. Student’s t tests were used for comparisons of two groups.
Corticosterone, blood glucose, food intake, bodyweight,HR, bloodpres-
sure, locomotor activity, and FST data over multiple time points were
analyzed using two-way or three-way repeated-measures ANOVA as ap-
propriate (time being the repeated measure), followed by protected least
significant difference post hoc analysis. Fisher’s least significant difference
was used for a priori planned comparisons across genotype and stress at
each time point. Area under the curve, behavioral data (EPM), body
composition data, RNAscope data, and immunoreactive cell counts were
analyzed using Student’s t test. Data were analyzed using Sigma Stat
(Systat) or Statistica (Statsoft) software. Statistical significance was set at
p 0.05. Data that did not fall in a normal distribution or equal variance
were log transformed and reanalyzed.
Results
Sim1-Cre selective KD of theGlp1rmRNA expression within
the PVN
We developed mice with PVN-directed Glp1r KD (Sim1-Cre;
Glp1r f/f) (Fig. 1A). Mice carrying Glp1r floxed allele (Glp1r f/f)
(Smith et al., 2014) were crossed with mice expressing Cre-
recombinase in Sim1 neurons (Balthasar et al., 2005). Sim1 is a
transcriptional factor that is highly expressed in the PVN.
Sim1-Cre; Glp1r f/f mice showed 70% reduction in Glp1r
mRNA expression in the PVN region (t(20) 2.85, p 0.05 vs
Glp1r f/f; Fig. 1B). Other brain areas that express Glp1r, includ-
ing the central nucleus of amygdala, the medial amygdala, the
SON, lateral septum, bed nucleus of the stria terminalis, the
NTS, and the arcuate nucleus, showed no significant differ-
ence in Glp1r mRNA expression between Sim1-Cre; Glp1r f/f
and Glp1r f/f mice, demonstrating the expected regional spec-
ificity of the Sim1-Cre gene expression (Fig. 1B). Moreover,
Glp1r mRNA expression was not significantly decreased in
extra-CNS tissues (adrenal gland, pituitary, heart, or kidney)
of Sim1-Cre; Glp1r f/f mice (Fig. 1B).
To verify furtherGlp1rKDand its relevance to theHPA axis at
the level of the PVN, we used RNAscope fluorescent in situ hy-
bridization to assess the following: (1) relative PVNGlp1rmRNA
expression in Glp1r KD versus Glp1r f/f animals; and (2) colocal-
ization to corticotropin-releasing hormone neurons of the PVN.
Fig. 1C confirms that Glp1r mRNA is expressed within the Crh-
enriched region in the PVN of Glp1r f/f mice and is markedly
reduced in the comparable region of Sim1-Cre;Glp1r f/f mice (Fig.
1C,D). The expression of Crh mRNA expression was similar in
both genotypes (Fig. 1E). These results verify efficiency Sim1-
Cre-mediatedGlp1rmRNAKD at the cellular level and is consis-
tent with the KD of mRNA by qPCR.
Figure1. Sim1-Cre-induced KD ofGlp1rwithin the PVN.A, Genetic strategy to deleteGlp1r in neurons expressing Cre through the Sim1 promoter.Mice carrying two conditionalGlp1r alleleswere
crossed to the Sim1-Cre line to excise the exons 6 and 7 of the Glp1r gene. B, Glp1rmRNA expression in various brain and peripheral tissues using primers specific for the amplicons spanning exons
6 and 7 in the Glp1r gene. The Sim1-Cre; Glp1r f/f mice showed70% reduction in Glp1rmRNA expressionwithin the PVN, but not in arcuate nucleus (ARC), central nucleus of amygdala (CEA), NTS,
medial amygdala (MeA), SON,bednucleusof stria terminalis (BST), lateral septum,pituitary (PIT), adrenal glands (ADR), heart (HRT), andkidney (KID).C, Representative imagesofRNAscopeanalysis
of theGlp1r (red) and Crh (green)within the PVN Crh-enriched region of theGlp1r f/f (top) and Sim1-Cre; Glp1r f/f (bottom).D, The expression ofGlp1rmRNAwas significantly reducedwithin the PVN
Crh-enriched region of the Sim1-Cre; Glp1r f/f mice compared with Glp1r f/f. E, The expression of Crhwas similar in both genotypes. Data are mean SEM. Scale bar: C, 20m. *
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Glp1rKD in Sim1 neurons attenuates neuroendocrine
response to acute stress
Sim1-Cre; Glp1r f/f and Glp1r f/f mice were tested for basal (circa-
dian) HPA axis regulation and responses to acute stress. There
was no difference in peak or nadir corticosterone concentrations
between Sim1-Cre; Glp1r f/f andGlp1r f/f mice, indicating an intact
diurnal HPA axis rhythm (Fig. 2A) (F(1,35) 40.24, p 0.001 vs
A.M., n 9 per group). To test the necessity of PVNGlp1r for the
HPA axis regulation during acute stress, Sim1-Cre; Glp1r f/f and
Glp1r f/f littermates were subjected to restraint stress, a common
test used to assess psychogenic stress responses (Furay et al.,
2008). The plasma ACTH response to restraint was reduced in
Sim1-Cre; Glp1r f/f mice (Fig. 2B) (t(10)  4.616, p  0.001 vs
Glp1r f/f, n 6 per group), consistent with GLP-1-mediated acti-
vation of the HPA axis. Similarly, both time course (Fig. 2C) and
integrated area under the curve (Fig. 2D) plasma corticosterone
responses were significantly diminished in the Sim1-Cre; Glp1r f/f
mice relative to Glp1r f/f littermates (F(3,71) 156.84, main effect
of time, p 0.05; F(1,71) 7.76main effect of genotype, p 0.05;
F(3,71)  3.00, p  0.05, time  genotype interaction; Fig. 2C;
t(16)  3.47, p  0.003, vs Glp1r
f/f; Fig. 2D). PVN neuronal
activation in the Sim1-Cre: Glp1r f/f mice following restraint, as-
sessed by Fos expression, was also significantly reduced (t(10) 
2.50, p 0.05 vsGlp1r f/f; Fig. 2E), consistent with decreased PVN
drive in the absence of PVN GLP-1 signaling. We next tested
whether diminishedHPA axis responses in the Sim1-Cre;Glp1r f/f
was generalizable to other stressmodalities. PVNKD and control
littermates were exposed to hypoxia (8% oxygen) for 30 min.
Hypoxia-induced corticosterone responses were significantly re-
duced in the Sim1-Cre; Glp1r f/f mice (t(16)2.51, p 0.02 vs
Glp1r f/f; Fig. 2F). Brain GLP-1 signaling has been reported to
regulate glucose metabolism (Ghosal et al., 2013). Notably, in
response to restraint stress or hypoxia, there was no difference in
blood glucose between the PVNGlp1rKD and control mice (Fig.
2G), suggesting that neuronal Glp1 projections to the PVN are
not required for regulation of glucose homeostasis under the
specific conditions tested. Importantly, we did not observe dis-
ruption of circadian corticosterone secretion or enhanced HPA
axis responses to restraint in mice carrying the Sim1-Cre trans-
gene on a wild-type background (Fig. 2 H, I), confirming that
alterations in HPA axis function are due to Sim1-directed Glp1r
KD rather than the presence of the Sim1-Cre transgene alone.
Collectively, these data indicate that GLP-1 signaling in the PVN
is essential for full activation of the HPA axis during psychogenic
as well as physiologic stress, and mediated by a circuit distinct
from those controlling glucose regulation.
Glp1rKD in the Sim1 neurons attenuates neuroendocrine
response to chronic stress
To investigate a potential role for PVN GLP-1 signaling in key
physiological responses to chronic stress, we subjected Sim1-Cre;
Glp1r f/f and Glp1r f/f littermates to a 2 week CVS regimen (Table
1) or maintained them under standard housing conditions (no
CVS). The CVS paradigm is a well-characterized model of
chronic stress in rodents that produces physiological (attenuated
weight gain), neuroendocrine (HPA axis facilitation), and behav-
ioral adaptations (anxiety- and depression-related behaviors)
(Furay et al., 2008). We observed a CVS-induced reduction of
body weight during week 1 of CVS in both genotypes (F(1,25) 
37.90, p 0.05 vs no CVS; Fig. 3A). However, during week 2, the
CVS-exposed Sim1-Cre; Glp1r f/f mice showed significantly less
body weight loss than CVS-exposed Glp1r f/f mice (F(1,25) 5.19,
Figure 2. Sim1-Cre-induced KD of Glp1r attenuates HPA axis responses to acute stress. A, Basal circadian nadir and peak corticosterone concentrations in Sim1-Cre; Glp1r f/f and Glp1r f/f mice
(n 9 per group). Both genotypes exhibited intact circadian regulation of corticosterone secretion. B, Reduced peak ACTH response after a 20min acute restraint stress in Sim1-Cre; Glp1r f/f mice.
C, Decreased corticosterone (time course) response to a novel 30min restraint challenge in Sim1-Cre; Glp1r f/f mice.D, Reduced integrated corticosterone response in Sim1-Cre; Glp1r f/f. E, Decreased
Fos induction in the PVNof the Sim1-Cre; Glp1r f/f after a novel 30min restraint challenge. F, Sim1-Cre; Glp1r f/fmice exhibited significantly reduced integrated corticosterone response after exposure
to a novel 30min hypoxia (systemic stress).G, Blood glucose levelsmeasured over the stress time-points during both acute restraint and hypoxia showed no significant differences between the two
genotypes (n 9 per group). H, Basal nadir and peak corticosterone concentration in wild-type and Sim1-Cremice showed no significant differences. There were significant differences between
P.M. corticosterone level andA.M. corticosterone in both genotypes ( p 0.05), but no genotype-related differences (n 7 per group). I, The time course of the corticosterone response to a 30min
restraint challenge did not differ between the two genotypes. Data are mean SEM. *p 0.05 vs Glp1r f/f.
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p 0.05 vsGlp1r f/f -CVS; Fig. 3A), suggesting that GLP-1 signal-
ing may contribute to weight loss observed in rodent as a conse-
quence of chronic stress. Importantly, Sim1-Cre; Glp1r f/f and
littermates Glp1r f/f did not differ in body weight at the outset of
the study (Table 2), indicating that Glp1r KD by itself has no
effect on body weight under nonstressed conditions. To assess
HPA axis facilitation following chronic stress, Sim1-Cre; Glp1r f/f
and littermates Glp1r f/f were submitted to a novel acute restraint
stress, with plasma corticosterone levels as the primary outcome
measure (Fig. 3B). We found that the corticosterone response to
novel stress was increased in CVS-exposed Glp1r f/f mice relative
to non-CVS controls (F(3,75) 208.36; p 0.05, main effects of
time; F(1,25)  17.82; p  0.05, main effects of genotype; Figure
3B), consistent with expected stress facilitation of the HPA axis
(Bhatnagar and Dallman, 1998). In contrast, CVS did not affect
the magnitude of the novel stress responses in the Sim1-Cre;
Glp1r f/f group (p 0.05; Fig. 3B,C), suggesting that GLP-1 sig-
naling is required for chronic stress sensitization of the HPA axis.
Again, despite the observed differences in
HPAaxis stress responses, therewereno sig-
nificant differences in blood glucose levels
among the genotypes (Fig. 3D).
PVNGlp1r signaling is required for
stress-induced cardiovascular
responses
To investigate whether PVN Glp1r-
expressing neurons also contribute to
sympathetic nervous system cardiovascu-
lar responses to acute stress, HR andMAP
were measured under resting and stressed
conditions in Sim1-Cre; Glp1r f/f and
Glp1r f/f littermate controls using radiote-
lemetry. Baseline studies showed that
both Sim1-Cre; Glp1r f/f and controls
showed similar circadian patterns of car-
diovascular function (Fig. 4A–C) (F(1,29)
 112.29; p  0.05, main effects of time;
Fig. 4A; F(1,29)  186.19; p  0.05, main
effects of time; Fig. 4C). In contrast, fol-
lowing a novel restraint (30 min) stress,
MAP (F(1,52) 34.54, p 0.05 vsGlp1r
f/f;
Fig. 4D,E) and HR (F(1,52)  13.30, p 
0.05 vsGlp1r f/f; Fig. 4F,G) responses were
significantly attenuated in Sim1-Cre;
Glp1r f/f (p  0.05 vs Glp1r f/f) relative to
their littermate controls. There were no
differences in general locomotion. To
assess the mechanism of Glp1r action,
cardiovascular stress responses were
measured during autonomic blockade.
Propranolol (a nonselective -adrenergic re-
ceptor antagonist) decreased HR to a
lesser extent in Sim1-Cre; Glp1r f/f mice
compared with control (p  0.05; Fig.
4H). In contrast, no genotype differences
were observed after parasympathetic
blockade with atropine (a cholinergic
muscarinic receptor antagonist) (Fig.
4H). Finally, there was no difference be-
tween the genotypes in the increase in HR
(Fig. 4I) following total ganglionic (auto-
nomic) blockade, suggesting that the in-
trinsic properties of the heart were not altered by Glp1r KD.
Together, these results indicate that PVN Glp1r signaling en-
hances stress-induced HR responses predominantly through ac-
tivation of sympathetic drive to the heart.
Sim1 Glp1r KD reduces anxiety-like behaviors
Behavioral responses are an important part of adaptation to
stress. To determine the effect of PVN GLP-1R on behavioral
stress responses, stress-naive Sim1-Cre; Glp1r f/f mice and their
littermate Glp1r f/f controls were tested in an EPM. In addition,
for the assessment of stress-induced behavioral reactivity, a
separate cohort of Sim1-Cre; Glp1r f/f mice and their littermate
Glp1r f/f controls were exposed to stressors (FST and rotation)
on the day before the EPM testing. The Sim1-Cre;Glp1r f/f mice
spent more time in the open arm of the EPM (t(16) 4.50, p
0.05 vs Glp1r f/f; Fig. 5A) compared with littermates Glp1r f/f
controls. Moreover, increased time in the open arm was also
observed in mice exposed to prior stressors (t(12)  2.70,
Figure 3. GLP-1 receptor KD diminishes chronic stress responses. A, CVS caused a significant reduction in percentage body
weight in both Sim1-Cre; Glp1r f/f and Glp1r f/f during week 1. #p 0.05 versus respective no CVS control. After week 1, Sim1-Cre;
Glp1r f/f displayed significantly less bodyweight loss relative to Glp1r f/f CVS-exposedmice. #Significant difference from respective
no CVS control. *Significant difference from Glp1r f/f-CVS exposed mice. B, C, Time course (B) and integrated corticosterone
response (C) to a novel 30 min restraint challenge in Glp1r f/f and Sim1-Cre; Glp1r f/f mice. Statistical analysis revealed that CVS
Glp1r f/f mice had significantly higher corticosterone response than no CVS Glp1r f/f. CVS Sim1-Cre; Glp1r f/f mice showed signifi-
cantly decreased corticosterone at the 30 min time point compared with CVS Glp1r f/f mice. There were no significant differences
between the CVS-exposed and no CVS Sim1-Cre; Glp1r f/f in the corticosterone response. Regardless of the CVS assignment,
integrated stress response to restraint stress was significantly reduced in the Sim1-Cre; Glp1r f/f compared with Glp1r f/f. #Signifi-
cant difference from respective no CVS control. *Significant difference from respective Glp1r f/f. D, Integrated glucose response to
a novel 30min restraint challenge inGlp1r f/f and Sim1-Cre; Glp1r f/fmice showedno effect of genotype. However, therewas amain
effect of stress, and area under the curve glucose was reduced in both genotypes following CVS exposure. *Significant difference
from respective no CVS controls. Data are mean SEM.
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p  0.05 vs Glp1r f/f; Fig. 5B), suggesting a resistance pheno-
type of the Sim1-Cre;Glp1r f/f mice to the impact of prior stress
on anxiety-like responses. There was no significant effect of
Glp1rKD on forced swim behavior (either acutely or following
1 d of CVS), measured as the time spent in the immobility
behavior measuring immobility duration (Fig. 5C), suggesting
the selectivity of Glp1r signaling for anxiety-related behaviors,
but not behavioral despair. Notably, there were no differences
in total distance traveled in the EPM, indicating that differ-
ences in activity do not account for behavioral changes
(Fig. 5D).
Sim1-Cre Glp1r KD does not alter food intake, and body
composition in the absence of experimental stress
GLP-1 signaling in the brain regulates both energy and glucose
homeostasis (Barrera et al., 2011). Thus, it is possible that meta-
bolic actions of GLP-1 may modulate stress endpoints. To deter-
mine whether Sim1-mediated Glp1r KD disrupts resting
metabolic function, 24 h food intake was measured in Sim1-Cre;
Glp1r f/f and Glp1r f/f mice fed either chow or high fat diet. No
differences were noted in 24 h food intake (p	 0.05 vs Glp1r f/f;
Fig. 6A) during exposure to either diet, indicating that PVNGlp1r
signaling is not necessary for the regulation of food intake under
these conditions. Because Glp1r agonists are known to reduce
food intake (Kinzig et al., 2003), the response to Ex-4, a Glp1r
agonist, was assessed in chow-fed mice. Acute administration of
Ex-4 reduced food intake in both cohorts (p  0.05 vs saline
controls; Fig. 6B) but was independent of Sim1-Cre Glp1r KD
(p	 0.05 vsGlp1r f/f; Fig. 6C). Similarly, therewere nodifferences
in body weight or body composition (fat mass and lean mass)
between the Sim1-Cre;Glp1r f/f andGlp1r f/f mice (Fig. 6C). These
data suggest that Glp1r signaling is not required for aspects of
energy homeostasis tested in our experiments. These data are in
contrast with efficacy of PVN Glp1r KD in prevention of chronic
stress-induced weight loss, suggesting that the latter effect is
driven bymodulations of stress responsemagnitude at the level of
the PVN.
Discussion
The results here provide direct evidence that GLP-1, a peptide
neurotransmitter with CNS production largely limited to the
hindbrain (Campbell and Drucker, 2013), is necessary in the co-
ordination of physiological as well as behavioral responses to
stress. Here, we used PVN-targetedGlp1rKD to demonstrate the
intimate relationship between PVNGLP-1 signaling and physio-
logic and emotional reactivity to stress. Mice lacking theGlp1r in
the PVN have reduced HPA axis responses to both acute and
chronic stress, show reduced chronic stress facilitation of HPA
axis responses, and display reduced anxiety-like behavior as as-
sessed in the EPM, both under basal conditions and following
prior stress exposure. Moreover, Glp1r KD attenuated stress-
induced cardiovascular responses, associated with decreased
sympathetic drive to the heart. Finally, Glp1r KDmice were pro-
tected against chronic stress-induced body weight loss. These
data indicate that a monosynaptic connection between NTS
GLP-1 neurons and GLP-1-receptive neurons in the PVN is re-
quired for appropriate integration of the whole-organism re-
sponse to both acute and chronic stress.
Putative role of GLP-1 signaling in PVN Sim1-positive
neurons in mediating multiple aspects of general stress
integration
Establishing the mechanism of action of GLP-1 on stress reactiv-
ity has been confounded by uncertainty about the extent towhich
gut-derived GLP-1 in the circulation crosses the blood–brain
barrier to influence CNS functions (Kanoski et al., 2011), and the
possibility of indirect effects from peripheral GLP-1 systems
(Heppner et al., 2015). Consequently, results from studies of
mice with global knock-out of the Glp1r are difficult to interpret
(Scrocchi et al., 1996; MacLusky et al., 2000). In this study, we
used targeted KD of Glp1r in the PVN, a central hypothalamic
node mediating stress responses as well as a major target of NTS
proglucagon neuronal projections (Merchenthaler et al., 1999;
Vrang et al., 2007). Similar to the effectiveness of the Sim1-Cre
mouse line to KD or rescue other target genes in the PVN
(Balthasar et al., 2005; Solomon et al., 2015), Sim1-Cre; Glp1r f/f
mice exhibited tissue-specific reduction of Glp1rmRNA expres-
sion by both qPCR and RNAscope cellular localization.
In addition to robust expression in PVN, Sim1 is expressed in
the SON, medial amygdala, posterior hypothalamic nuclei, pre-
mammillary nucleus, and nucleus of the lateral olfactory tract
(Balthasar et al., 2005). Moreover, a recent study using reporter
mice demonstrates, in addition to high density of GLP-1 receptor
expression throughout the hypothalamus, GLP-1 receptor is also
expressed in bed nucleus of stria terminalis, lateral septum, and
medial and basolateral amygdala (Cork et al., 2015). Therefore, to
rule out an impact of altered Glp1r expression in these brain
regions on the phenotype observed, we performed qPCR-based
assessments in micropunches obtained from known Glp1r-
expressing regions implicated in stress regulation. With the ex-
ception of the PVN, we observed no significant difference in
Glp1r expression compared with wild-type littermates. (We were
somewhat surprised by the lack of a significant downregulation in
the SON but feel this is likely due to dilution of circular punches
with neighboring Glp1r-expressing regions, such as the medial
amygdala). Moreover, there is limited evidence of a significant
direct role for the GLP-1 signaling in these brains regions in
autonomic or behavioral stress responses. These data are
supported by a recent comprehensive study characterizing the
expression of Glp1r in the monkey and rat using in situ hybrid-
ization, ligand binding, and immunocytochemistry, which re-
vealed minimal expression in the majority of Sim1-expressing
regions, including the medial amygdala, ventromedial hypothal-
amus, and lateral/dorsal hypothalamus (Heppner et al., 2015).
Therefore, it is unlikely that the results of our studies are the
result of deletion ofGLP-1R in regions other than the PVN. Thus,
the PVN stands out as the most likely mediator of the reduced
stress phenotype in the Sim1-Cre; Glp1r f/f mice.
Although striking that the general physiologic endpoint of
weight loss predictably during CVS is largely reversed in the
Sim1cre- Glp1r f/f mice, other aspects of energy homeostasis tested
in our experiments appear to be less affected. The data suggest
Table 2. Initial body weight, adrenal weight and thymus weight of Glp1r f/f and
Sim1-Cre; Glp1r f/f mice with or without a history of chronic stress.
No CVS CVS
Glp1rf/f
Sim1-Cre;
Glp1rf/f Glp1rf/f
Sim1-Cre;
Glp1rf/f
Initial BW (g) 26.88 1.14 27.55 1.16 28.76 0.75 28.84 0.88
Normalized adrenal
(mg/100g*body
weight) 0.008 0.001 0.012 0.001 0.011 0.001 0.010 0.001
Normalized thymus
(mg/100g*body
weight) 0.13 0.03 0.12 0.02 0.13 0.01 0.13 0.02
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that stress effects through regions in which Glp1r is reduced by
Sim1cre, including those on bodyweight, aremediated by specific
pathways that are largely independent of GLP-1 effects on energy
balance in unstressed animals. This conclusion is consistent with
a recent study indicating that central GLP-1 contributes predom-
inantly to the ability of acute psychological stressor to inhibit
food intake but has no effect on baseline food intake in the ab-
sence of stress (Maniscalco et al., 2015). Furthermore, it is tempt-
ing to speculate that primary effects ofGLP-1 onmetabolismmay
be mediated by receptors in other brain regions. Indeed, many
studies have identified other brains regions, including the ventral
tegmental area (Alhadeff and Grill, 2014), nucleus accumbens
(Dossat et al., 2011), hippocampus (Kanoski and Grill, 2015),
parabrachial nucleus (Swick et al., 2015), andNTS (Barrera et al.,
2011) are sufficient for mediating central GLP-1-/Ex-4-induced
suppression of food intake and for regulation of energy
homeostasis.
Preferential role of Sim1 GLP-1 signaling in mediating
anxiety-like but not depression-like behaviors
In the current study, we noted a preferential involvement of the
Sim1-Cre-induced decreased Glp1r signaling in mediating
anxiety-like behavior, but not depression-like behavior, suggest-
ing specific anxiolytic effects of PVN Glp1r deletion, at least as
Figure4. Sim1-Cre Glp1rKDattenuates cardiovascular responses to acute restraint.A–C, Baseline recordings of bloodpressure (A), HR (B), and total activity (C) revealedno significant differences
between the genotypes. There weremain effects of time on blood pressure and activity, consistent with known circadian patterns.D–G, Exposure to acute restraint induced significant increases in
blood pressure (MAP) andHR (BPM) thatwere attenuated in Sim1-Cre; Glp1r f/f mice. *Significant difference fromGlp1r f/f (n 7 or 8 per group).H, Sim1-Cre; Glp1r f/f mice showed less sympathetic
cardiac tone following restraint, but therewasnodifference in theparasympathetic drive to theheart. I, HR response following total ganglionic blockadewithhexamethoniumdidnotdiffer between
the genotypes. Data are mean SEM.
Figure 5. Decreased anxiety-like behavior following KD of Glp1r in Sim1 neurons. A, Sim1-Cre; Glp1r f/f mice exhibited more open arm time in the EPM than their littermates Glp1r f/f
under basal conditions. B, Sim1-Cre; Glp1r f/f exhibited increased exploration into the open arm following prior stress exposure (10 min FST
 1 h rotation on a platform shaker on the
day before testing). *Significant difference from Glp1r f/f. C, There was no significant effect of Glp1r KD on immobility in the FST. D, There was no genotype difference in locomotion in the
EPM.
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assessed in the EPM. Although PVN involvement in HPA axis
and cardiovascular regulation is known, it is not commonly im-
plicated in behavioral stress responses. However, prior studies
indicate that lesions of the PVN can reduce behavioral indices of
arousal (Herman et al., 1991), and recent evidence suggests that
PVN neurons project to forebrain regions implicated in emo-
tional regulation (e.g., medial and central amygdaloid nuclei)
(Knobloch et al., 2012), suggesting a possible role in anxiogenesis.
Alternatively, sympatho-excitation can be accompanied by acti-
vation of central systems that promote anxiety responses. Given
that Sim1-Cre-directedGlp1rKD reduces peripheral sympathetic
responses, this impaired signaling may also constrain central
pathways activated by, or occurring in tandem with, peripheral
responses. The lack of Glp1r KD and/or significant Glp1r expres-
sion in themedial and central amygdalamakes it unlikely that the
decrease in anxiety-like behavior is due to altered GLP1R signal-
ing in these regions.
In the current study, anxiety-like behavior was assessed in the
EPM. Although this test captures passive versus exploratory as-
pects of anxiety, it is not sufficient to fully define an “anxious”
phenotype (better assessed with multiple tests), and we therefore
limit our interpretation to this test. However, it is important to
note that expression of anxiety-like behaviors (e.g., increased
open arm time) replicated across two cohorts tested under
different conditions, supporting the reproducibility of the EPM
findings.
Autonomic substrate of the Sim1 GLP-1-mediated
cardiovascular responses
Attenuated stress-induced blood pressure and HR responses in
Sim1-Cre; Glp1r f/f mice was at least in part due to reduced
sympathetic drive to the heart, as evidenced by attenuated brady-
cardia following blockade of sympathetic drive. This is consistent
with observations that intracerebroventircular GLP-1 administra-
tionactivates sympatheticpreganglionicneurons inautonomic con-
trol sites, increasingHR and blood pressure (Yamamoto et al., 2002,
2003). Moreover, preganglionic neurons receive direct projections
from GLP-1-expressing cell groups in the brainstem and GLP-1-
receptivePVNneurons, consistentwith a role of endogenousGLP-1
in autonomic activation (Isbil-Buyukcoskun and Gulec, 2004). The
altered cardiovascular responses in our study were robust and have
potentially important clinical implications. A variety of therapeutic
agents manipulating GLP-1 activity (e.g., long-acting GLP-1 ago-
nists) and inhibitors of dipeptidyl-peptidase 4 are nowbeing used in
the treatment of diabetes and diabetes-related obesity (Zoicas et al.,
2013). Of particular concern is that long-actingGLP-1 agonistsmay
penetrate into theCNS to exert untoward effects on autonomic con-
trolled cardiovascular functions. InfusionsofGLP-1orEx-4 into the
CNS show increased blood pressure and increased HR (Yamamoto
etal., 2002), andhumanstudies reveal a smallbut significant increase
in HR in patients treated with either Ex-4 or liraglutide (Buse et al.,
2009). Our Sim1-Cre mouse studies suggest a mechanism whereby
GLP-1 agonists may have cardiovascular effects in the context of
stress, a possibility that warrants further investigation.
In conclusion, together, our study suggests that GLP-1 neu-
rons projecting to the PVN from the NTS have a unique and
essential function in adaptation to both acute and chronic stress.
The importance of GLP-1 in global stress integration suggests
that it may play a role in pathologies characterized by dysregula-
tion of multiple stress systems, such as depression (enhanced
HPA axis activity, cardiovascular pathology, comorbid anxiety)
and post-traumatic stress disorder (decreased HPA axis activity,
autonomic over-reactivity, anxiety). Moreover, GLP-1 receptor
agonists, acting both peripherally and centrally, are widely used
in treatment of Type II diabetes, necessitating consideration of
central stress-excitatory actions of GLP-1 as a potential compli-
cating factor for chronic treatment.
References
Alhadeff AL, Grill HJ (2014) Hindbrain nucleus tractus solitarius glucagon-
like peptide-1 receptor signaling reduces appetitive and motivational as-
pects of feeding. Am J Physiol 307:R465–R470. CrossRef Medline
Balthasar N, Dalgaard LT, Lee CE, Yu J, Funahashi H,Williams T, FerreiraM,
TangV,McGovern RA, Kenny CD, Christiansen LM, Edelstein E, Choi B,
Boss O, Aschkenasi C, Zhang CY, Mountjoy K, Kishi T, Elmquist JK,
Lowell BB (2005) Divergence of melanocortin pathways in the control
of food intake and energy expenditure. Cell 123:493–505. CrossRef
Medline
Barrera JG, Jones KR,Herman JP,D’AlessioDA,Woods SC, Seeley RJ (2011)
Hyperphagia and increased fat accumulation in two models of chronic
CNS glucagon-like peptide-1 loss of function. J Neurosci 31:3904–3913.
CrossRef Medline
Bhatnagar S, Dallman M (1998) Neuroanatomical basis for facilitation of
hypothalamic-pituitary-adrenal responses to a novel stressor after
chronic stress. Neuroscience 84:1025–1039. CrossRef Medline
Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma
Figure 6. Sim1-Cre Glp1r KD does not alter food intake or body weight in the absence of stress. A, There were no significant genotype differences in food intake (under either normal chow or
high-fat diet conditions).B, There were no genotype effects in response to the Glp1r agonist Ex-4. #Significant difference from respective saline control (n 7 or 8 per group). C, Body composition
showed no significant difference between the two genotypes (n 7 or 8 per group).
192 • J. Neurosci., January 4, 2017 • 37(1):184–193 Ghosal et al. • Glucagon-Like Peptide 1 and Stress Excitation
M, Blonde L (2009) Liraglutide once a day versus exenatide twice a day
for type 2 diabetes: a 26-week randomised, parallel-group, multinational,
open-label trial (LEAD-6). Lancet 374:39–47. CrossRef Medline
Campbell JE, Drucker DJ (2013) Pharmacology, physiology, and mecha-
nisms of incretin hormone action. Cell Metab 17:819–837. CrossRef
Medline
Carter JR, Goldstein DS (2015) Sympathoneural and adrenomedullary re-
sponses to mental stress. Compr Physiol 5:119–146. CrossRef Medline
Chrousos GP, Gold PW (1992) The concepts of stress and stress system
disorders: overview of physical and behavioral homeostasis. JAMA 267:
1244–1252. CrossRef Medline
Cork SC, Richards JE, Holt MK, Gribble FM, Reimann F, Trapp S (2015)
Distribution and characterisation of Glucagon-like peptide-1 receptor
expressing cells in the mouse brain. Mol Metab 4:718–731. CrossRef
Medline
de Kloet ER, Joe¨ls M, Holsboer F (2005) Stress and the brain: from adapta-
tion to disease. Nat Rev Neurosci 6:463–475. CrossRef Medline
Dossat AM, Lilly N, Kay K, Williams DL (2011) Glucagon-like peptide 1
receptors in nucleus accumbens affect food intake. J Neurosci 31:14453–
14457. CrossRef Medline
Furay AR, Bruestle AE, Herman JP (2008) The role of the forebrain gluco-
corticoid receptor in acute and chronic stress. Endocrinology 149:5482–
5490. CrossRef Medline
Ghosal S,MyersB,HermanJP (2013) Roleof central glucagon-likepeptide-1 in
stress regulation. Physiol Behav 122:201–207. CrossRefMedline
Ghosal S, Bundzikova-Osacka J, Dolgas CM, Myers B, Herman JP (2014)
Glucocorticoid receptors in the nucleus of the solitary tract (NTS) de-
crease endocrine and behavioral stress responses. Psychoneuroendocri-
nology 45:142–153. CrossRef Medline
GrippoAJ (2009) Mechanisms underlying alteredmood and cardiovascular
dysfunction: the value of neurobiological and behavioral research with
animal models. Neurosci Biobehav Rev 33:171–180. CrossRef Medline
Heppner KM,KirigitiM, Secher A, Paulsen SJ, BuckinghamR, PykeC, Knud-
sen LB, Vrang N, Grove KL (2015) Expression and distribution of
glucagon-like peptide-1 receptormRNA, protein and binding in themale
nonhuman primate (Macaca mulatta) brain. Endocrinology 156:255–
267. CrossRef Medline
Herman JP, Thomas GJ, Wiegand SJ, Gash DM (1991) Lesions of parvocel-
lular subdivisions of the hypothalamic paraventricular nucleus alter open
field behavior and acquisition of sensory and spatial discrimination. Brain
Res 550:291–297. CrossRef Medline
Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R,
Scheimann J,Myers B (2016) Regulation of the hypothalamic-pituitary-
adrenocortical stress response. Compr Physiol 6:603–621. CrossRef
Medline
Isbil-Buyukcoskun N, Gulec G (2004) Effects of intracerebroventricularly
injected glucagon-like peptide-1 on cardiovascular parameters: role of
central cholinergic system and vasopressin. Regul Pept 118:33–38.
CrossRef Medline
Kanoski SE, Grill HJ (2015) Hippocampus contributions to food intake
control: mnemonic, neuroanatomical, and endocrine mechanisms. Biol
Psychiatry piiS0006–3223(15)00771–4.
Kanoski SE, Fortin SM, Arnold M, Grill HJ, Hayes MR (2011) Peripheral
and central GLP-1 receptor populations mediate the anorectic effects of
peripherally administered GLP-1 receptor agonists, liraglutide and
exendin-4. Endocrinology 152:3103–3112. CrossRef Medline
Kinzig KP, D’Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF,
Murphy EK, Seeley RJ, Figueredo HF (2003) CNS glucagon-like
peptide-1 receptors mediate endocrine and anxiety responses to intero-
ceptive and psychogenic stressors. J Neurosci 23:6163–6170. Medline
Knobloch HS, Charlet A, Hoffmann LC, Eliava M, Khrulev S, Cetin AH,
OstenP, SchwarzMK, Seeburg PH, StoopR,GrinevichV (2012) Evoked
axonal oxytocin release in the central amygdala attenuates fear response.
Neuron 73:553–566. CrossRef Medline
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real-time quantitative PCR and the 2(T)(-Delta Delta C) method.
Methods 25:402–408. CrossRef Medline
MacLuskyNJ, Cook S, Scrocchi L, Shin J, Kim J, Vaccarino F, Asa SL, Drucker
DJ (2000) Neuroendocrine function and response to stress in mice with
complete disruption of glucagon-like peptide-1 receptor signaling. Endo-
crinology 141:752–762. CrossRef Medline
Maniscalco JW, Zheng H, Gordon PJ, Rinaman L (2015) Negative energy
balance blocks neural and behavioral responses to acute stress by “silenc-
ing” central glucagon-like peptide 1 signaling in rats. J Neurosci 35:
10701–10714. CrossRef Medline
Merchenthaler I, Lane M, Shughrue P (1999) Distribution of pre-pro-
glucagon and glucagon-like peptide-1 receptormessenger RNAs in the rat
central nervous system. J Comp Neurol 403:261–280. CrossRef Medline
Paxinos G, Franklin K (2004) The mouse brain in stereotaxic coordinates,
Ed 4. San Diego: Elsevier/Academic.
Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL,
Drucker DJ (1996) Glucose intolerance but normal satiety in mice with
a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med
2:1254–1258. CrossRef Medline
Sisley S, Gutierrez-Aguilar R, Scott M, D’Alessio DA, Sandoval DA, Seeley RJ
(2014) Neuronal GLP1R mediates liraglutide’s anorectic but not
glucose-lowering effect. J Clin Invest 124:2456–2463. CrossRef Medline
Smith EP, An Z, Wagner C, Lewis AG, Cohen EB, Li B, Mahbod P, Sandoval
D, Perez-Tilve D, Tamarina N, Philipson LH, Stoffers DA, Seeley RJ,
D’Alessio DA (2014) The role of beta cell glucagon-like peptide-1 sig-
naling in glucose regulation and response to diabetes drugs. Cell Metab
19:1050–1057. CrossRef Medline
Solomon MB, Loftspring M, de Kloet AD, Ghosal S, Jankord R, Flak JN,
Wulsin AC, Krause EG, Zhang R, Rice T,McKlveen J,Myers B, Tasker JG,
Herman JP (2015) Neuroendocrine function after hypothalamic deple-
tion of glucocorticoid receptors in male and female mice. Endocrinology
156:2843–2853. CrossRef Medline
Swick JC, Alhadeff AL, Grill HJ, Urrea P, Lee SM, Roh H, Baird JP (2015)
Parabrachial nucleus contributions to glucagon-like peptide-1 receptor
agonist-induced hypophagia. Neuropsychopharmacology 40:2001–2014.
CrossRef Medline
TauchiM, ZhangR,D’AlessioDA, Stern JE,Herman JP (2008) Distribution
of glucagon-like peptide-1 immunoreactivity in the hypothalamic
paraventricular and supraoptic nuclei. J Chem Neuroanat 36:144–149.
CrossRef Medline
Ulrich-Lai YM, Herman JP (2009) Neural regulation of endocrine and auto-
nomic stress responses. Nat Rev Neurosci 10:397–409. CrossRefMedline
Varndell IM, BishopAE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM (1985)
Localization of glucagon-like peptide (Glp) immunoreactants in human
gut and pancreas using light and electron-microscopic immunocyto-
chemistry. J Histochem Cytochem 33:1080–1086. CrossRef Medline
Vrang N, Hansen M, Larsen PJ, Tang-Christensen M (2007) Characteriza-
tion of brainstem preproglucagon projections to the paraventricular and
dorsomedial hypothalamic nuclei. Brain Res 1149:118–126. CrossRef
Medline
Yamamoto H, Lee CE, Marcus JN, Williams TD, Overton JM, Lopez ME,
Hollenberg AN, Baggio L, Saper CB, Drucker DJ, Elmquist JK (2002)
Glucagon-like peptide-1 receptor stimulation increases blood pressure
and heart rate and activates autonomic regulatory neurons. J Clin Invest
110:43–52. CrossRef Medline
YamamotoH, Kishi T, Lee CE, Choi BJ, FangH,Hollenberg AN, Drucker DJ,
Elmquist JK (2003) Glucagon-like peptide-1-responsive catecholamine
neurons in the area postrema link peripheral glucagon-like peptide-1with
central autonomic control sites. J Neurosci 23:2939–2946. Medline
Zoicas F, Droste M, Mayr B, Buchfelder M, Scho¨fl C (2013) GLP-1 ana-
logues as a new treatment option for hypothalamic obesity in adults:
report of nine cases. Eur J Endocrinol 168:699–706. CrossRef Medline
Ghosal et al. • Glucagon-Like Peptide 1 and Stress Excitation J. Neurosci., January 4, 2017 • 37(1):184–193 • 193
